Loading...
The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps
Biologic therapy is a new treatment option for patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Currently, the only biologic with Food and Drug Administration–approval status for CRSwNP is dupilumab. Several other biologics are likely to be approved for CRSwNP, including mepolizumab...
Saved in:
| Published in: | Ear Nose Throat J |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7980424/ https://ncbi.nlm.nih.gov/pubmed/33035132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0145561320964653 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|